Is a complete ERAS research report available?

No complete published report is available for Erasca, Inc. (ERAS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Erasca, Inc. (ERAS)

NASDAQ: ERAS · USD

$17.7

-0.44 (-2.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ERAS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	6.2B
Net income (ttm)	-277M
EPS (ttm)	-$0.96
Shares out	347.1M
Volume	4,196,031
Beta	0.66
Price target	$22.8	+28.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -277M
EPS (ttm): -$0.96
Market cap: 6.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ERAS indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001761918
Company name	Erasca, Inc.
Country	United States
Country code	US
Cusip	29479A108
Employees	103
Employees Change	-23%
Employees Change Percent	-18.25
Enterprise value	$5.8B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-16
Isin	US29479A1088
Last refreshed	2026-07-30
Market cap	$6.2B
Market cap category	Mid-Cap
Price	$17.72
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	ERAS
Website	https://www.erasca.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.5%
FCF yield	-1.49%
P/B ratio	14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-277M
Net Income Growth Years	1%
Profit Per Employee	$-2.7M
ROA	-17.92
Roa5y	-19.27
ROCE	-67.47
ROE	-69.86
Roe5y	-42.12
ROIC	-18.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	944.03%
Cagr3y	89.57%
Cagr5y	-2.39%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$461.2M
Cash	$243.8M
Current Assets	$253.8M
Current Liabilities	$26.7M
Debt	$46M
Debt Equity	$0.12
Equity	$393.5M
Liabilities	$67.7M
Long Term Assets	$207.5M
Long Term Liabilities	$41M
Net Cash	$362.6M
Net Cash By Market Cap	$5.89
Net Cash Growth	0.64%
Net Debt Equity	$-0.92
Tangible Book Value	$393.5M
Tangible Book Value Per Share	$1.27
WACC	7.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.52
Net Working Capital	$-11.4M
Quick ratio	9.27
Working Capital	$227.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.23%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	942.35%
200-day SMA	10.75
3Y total return	581.54%
50-day SMA	15.66
50-day SMA vs 200-day SMA	50over200
5Y total return	-11.4%
All Time High	24.47
All Time High Change	-27.58%
All Time High Date	2021-09-07
All Time Low	1.01
All Time Low Change	1,654.46%
All Time Low Date	2025-04-09
ATR	1.24
Beta	0.66
Beta1y	1.5
Beta2y	1.88
Ch YTD	376.3
High	18.45
High52	24.28
High52 Date	2026-04-23
High52ch	-27.02%
Low	17.13
Low52	1.33
Low52 Date	2025-09-03
Low52ch	1,232.33%
Ma50ch	13.13%
Price vs 200-day SMA	64.9%
RSI	49
RSI Monthly	71.93
RSI Weekly	61.81
Sharpe ratio	2.76x
Sortino ratio	4.6
Total Return	-8.23%
Tr YTD	376.3
Tr1m	10.68%
Tr1w	-9.17%
Tr3m	78.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	10
Analyst Price Target Top	$22
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.12
Operating Income	$-133.7M
Price target	$22.8
Price Target Change	$28.67
Price Target Change Top	$24.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	276,407,797%
Float Percent	79.63%
Shares Insiders	9.72%
Shares Institutions	72.31%
Shares Out	347,127,399
Shares Qo Q	7.22%
Shares Yo Y	8.23%
Short Float	11.13%
Short Ratio	4.99
Short Shares	8.86

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-118M
Adjusted OCF	-117,929,000
Average Volume	4,790,040.55x
Bv Per Share	1.27
CAPEX	$-81,000
Ch1m	10.68
Ch1w	-9.17
Ch1y	942.4
Ch3m	78.99
Ch3y	581.5
Ch5y	-11.4
Ch6m	74.93
Change	-2.42%
Change From Open	-1.56
Close	18.16
Days Gap	-0.88
Depreciation Amortization	3,008,000
Dollar Volume	74,353,669.3
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-293.2M
EBITDA	$-290.2M
EPS	$-0.96
F Score	1
FCF	$-91.4M
FCF EV Yield	-1.58x
FCF Per Share	$-0.26
Financing CF	245,727,000
Fiscal Year End	December
Founded	2,018
Investing CF	-177,670,000
Ipr	10.75
Iprfo	11.45
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	13.4
Ma150ch	32.22%
Ma20	18.9
Ma20ch	-6.23%
Net CF	-23,226,000
Next Earnings Date	2026-08-11
Open	18
Optionable	Yes
Position In Range	44.7
Post Close	17.72
Postmarket Change Percent	-1.02
Postmarket Price	$17.54
Ppne	40,877,000
Price Date	2026-07-29
Ptbv Ratio	15.63
Relative Volume	0.88x
Share Based Comp	26,646,000
Tr6m	74.93%
Us State	California
Volume	4,196,031

Erasca, Inc. (ERAS)

Coverage state: Market snapshot only — no published research

Generate the first ERAS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ERAS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ERAS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ERAS

Frequently asked questions